A New Treatment for Progressive Metastatic Pancreatic Cancer
Researchers are testing a new drug for second-line therapy (after initial treatment stops working) in metastatic pancreatic cancer.
AI Platform Reveals Hidden Biology of Tumor Formation
New Potential Early Detection Trial for Type 2 Diabetics
An affiliate of the Lustgarten Foundation, the largest private funder of pancreatic cancer research.
Brain Cancer Vaccine for Metastatic PNET
Researchers are testing a vaccine for PNET that targets a protein that is very abundant in many neuroendocrine tumors.
PRECEDE Trial Sets Survival Rate Goal
Dr. Raymond Wadlow explains how the PRECEDE trial aims to increase pancreatic cancer survival through earlier detection of high-risk people.
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Taking a Chance on a Clinical Trial
Reesa Levy traveled to find the right pancreatic cancer doctor for her, and then joined a clinical trial for a vaccine.
The Benefit of Multiple Clinical Trials
Dr. Ira Sharp knew that his best bet for surviving pancreatic cancer was to look for clinical trials as part of his treatment.